TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Smerud Medical Research Sweden AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 58 | 20 | 148 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | -44 | -74 | 52 |
EBITDA | -44 | -74 | 52 |
Total assets | 170 | 127 | 114 |
Current assets | 170 | 127 | 114 |
Current liabilities | 159 | 115 | 43 |
Equity capital | 11 | 12 | 71 |
- share capital | 9 | 10 | 10 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 6.5% | 9.4% | 62.3% |
Turnover per employee | 58 | 20 | 148 |
Profit as a percentage of turnover | -75.9% | -370.0% | 35.1% |
Return on assets (ROA) | -25.9% | -58.3% | 45.6% |
Current ratio | 106.9% | 110.4% | 265.1% |
Return on equity (ROE) | -400% | -616.7% | 73.2% |
Change turnover | 40 | -125 | 52 |
Change turnover % | 214% | -86% | 55% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.